financetom
Business
financetom
/
Business
/
Vee Healthtek Announces Acquisition of Precision Practice Management to Expand Ambulatory Market Footprint and Technology Capabilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vee Healthtek Announces Acquisition of Precision Practice Management to Expand Ambulatory Market Footprint and Technology Capabilities
Sep 29, 2025 6:16 AM

PLANO, Texas, Sept. 29, 2025 /PRNewswire/ -- Vee Healthtek, a leader in AI-enabled healthcare solutions, is pleased to announce its acquisition of Precision Practice Management (Precision). This strategic acquisition unites two trusted revenue cycle management companies with a shared commitment to improving financial performance and operational outcomes for healthcare organizations.

Founded in 1993 and based in St. Louis, Missouri, Precision leverages its expertise in custom practice management workflows, multispecialty billing, and consulting to create and implement cutting-edge software solutions. Its global teams of medical billing and coding experts work closely with clients to increase accuracy and efficiency across the revenue cycle.

Matt Michaels, CEO of Vee Healthtek, expressed his enthusiasm for the acquisition, stating, "I am thrilled to welcome Precision's management team and customers into the Vee Healthtek family. Like Vee Healthtek, Precision delivers tailored solutions focused on financial optimization, operational excellence, regulatory compliance, and meaningful process improvements. Together, we will combine decades of experience to maximize yield and ensure workflow efficiency for clients."

Michael Barnell, CEO of Precision, added, "In conversations with Vee Healthtek, it became clear that Vee Healthtek's industry leadership and Precision's broad revenue cycle expertise would provide enhanced technology enablement and reimbursement solutions for healthcare systems and medical groups. We are pleased to join forces in such an impactful manner and look forward to the opportunities that lie ahead."

As one company, Vee Healthtek's clients can expect expanded capabilities that empower providers to overcome reimbursement challenges and achieve stronger financial performance. With breakthrough advances in automation and AI technologies, an extensive solution portfolio, and a steadfast focus on customer satisfaction, the company is well-equipped to drive greater efficiency, innovation, and growth across the revenue cycle. Precision's deep technical expertise and robust customer relationships, paired with Vee Healthtek's history of industry-leading financial outcomes for clients, will enhance healthcare organizations' success through more comprehensive, scalable offerings. A unified force, Vee Healthtek will be better positioned to present agile solutions to providers' most pressing challenges.

About Vee Healthtek:

Vee Healthtek is a leading technology-enabled solutions provider and strategic partner to the nation's top healthcare organizations. Rooted in a history of innovation, Vee Healthtek is dedicated to delivering industry-best results backed by data and technology. With a comprehensive suite of solutions for payers and providers, we drive efficiency, accuracy, and maximized yield. For more information, please visit veehealthtek.com.

About Precision Practice Management:

Precision Practice Management (Precision) provides revenue cycle management, practice management, and technical support services to top hospitals and medical practices across the United States. As experts in billing and coding for over 40 medical specialties and software integrations for all major electronic health records (EHRs), Precision allows clients to achieve superior clinical and financial performance. Visit precisionpractice.com to learn more.

For additional information, please visit https://www.veehealthtek.com/about-us/news/press-releases/vee-healthtek-announces-acquisition-of-precision-practice-management.htm.

Contact:

Steve Meier

Vee Healthtek

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/vee-healthtek-announces-acquisition-of-precision-practice-management-to-expand-ambulatory-market-footprint-and-technology-capabilities-302569486.html

SOURCE Vee Healthtek, Inc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- (Updates with General Motors' ( GM ) comment in the second paragraph.) General Motors ( GM ) is planning to cut around 1,000 salaried positions globally in an attempt to streamline its operations, Bloomberg reported Friday, citing people familiar with the matter. In order to win in this competitive market, we need to...
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- Barinthus Biotherapeutics ( BRNS ) on Friday reported encouraging results from its ongoing phase 2b HBV003 trial for chronic hepatitis B. The study, involving 121 participants, assessed VTP-300 in combination with a low dose of anti-PD1 antibody nivolumab, and new data shows eight participants achieved complete HBsAg loss, while two met the criteria...
Novartis Says Talks for Prostate Cancer Treatment Close Without Deal
Novartis Says Talks for Prostate Cancer Treatment Close Without Deal
Nov 15, 2024
11:51 AM EST, 11/15/2024 (MT Newswires) -- Novartis (NVS) unit Novartis Pharmaceuticals Canada said Friday that negotiations with the pan-Canadian Pharmaceutical Alliance for Pluvicto, a treatment for patients with a certain type of prostate cancer, have closed without an agreement. This outcome is a significant setback for people living with [metastatic castration-resistant prostate cancer] whose cancer is progressing despite standard...
Global Dividend Growth Split Corp Renewing At-The-Market Equity Program
Global Dividend Growth Split Corp Renewing At-The-Market Equity Program
Nov 15, 2024
11:53 AM EST, 11/15/2024 (MT Newswires) -- Global Dividend Growth Split Corp (GDV.TO) on Friday said it renewed its at-the-market equity program (ATM program). Sales of Class A and preferred shares will be made by at-the-market distributions. The maximum gross proceeds from the issue of the shares will be $100 million each for Class A and preferred share. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved